Innoviva (INVA) Liabilities and Shareholders Equity (2010 - 2026)
Innoviva's Liabilities and Shareholders Equity was $1.7 billion in Q2 2026, up 27.7% from $1.33 billion a year earlier but down 7.3% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Liabilities and Shareholders Equity at Innoviva came in at $1.64 billion, up 25.7% from FY2024.
- Liabilities and Shareholders Equity has now increased for four consecutive years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $1.3 billion in FY2024 (+4.6%), $1.24 billion in FY2023 (+1.0%), $1.23 billion in FY2022 (+32.9%) and $926.4 million in FY2021 (-7.3%).
- Quarterly Liabilities and Shareholders Equity has moved between $887.24 million (Q3 2021) and $1.84 billion (Q1 2026) over five years.
- Compared with a year earlier, Liabilities and Shareholders Equity has increased for five straight quarters, with growth averaging 18.3% over the last seven quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q1 2026 (growth of 46.4%); the worst was Q4 2021 (a decline of 7.3%).
- Per Business Quant data, INVA's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $1.84 billion (Q1 2026), $1.64 billion (Q4 2025) and $1.43 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | 1.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Bn |
| Mar 31, 2026 | 1.84 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 926.40 Mn |
| Sep 30, 2021 | 887.24 Mn |
API Access
Innoviva Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();